✦ LIBER ✦

Antibody dependent cell-mediated cytotoxicity in different forms of rheumatoid arthritis patients

✍ Scribed by B. Misiewicz-Poltorak; M. Plachecka-Gutowska

Book ID: 105441324
Publisher: Springer
Year: 1984
Tongue: English
Weight: 552 KB
Volume: 3
Category: Article
ISSN: 0770-3198
DOI: 10.1007/bf02032336

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased Antibody-Dependent Cell-Mediat

Increased Antibody-Dependent Cell-Mediated Cytotoxicity by Monocytes from Patients with Rheumatoid Arthritis

✍ Paul H. Waytz; Steven D. Douglas 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

Antibody-dependent cell-mediated cytotox

Antibody-dependent cell-mediated cytotoxicity in rheumatoid arthritis. Effect of rheumatoid serum fractions on normal lymphocytes

✍ Martin A. Isturiz; Maria M. De E. De Bracco; Ana M. Pizzi; Jorge A. Manni 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

Different effector cell types in antibod

Different effector cell types in antibody-dependent cell-mediated cytotoxicity

✍ SANDERSON, C. J.; CLARK, I. A.; TAYLOR, G. A. 📂 Article 📅 1975 🏛 Nature Publishing Group 🌐 English ⚖ 228 KB

Deficient Lymphoid Cell-Mediated, PHA-In

Deficient Lymphoid Cell-Mediated, PHA-Induced Cytotoxicity in Rheumatoid Arthritis Patients

✍ F. WISLØFF; S. S. FRØLAND; J. B. NATVIG 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Susceptibility of rheumatoid and nonrheu

Susceptibility of rheumatoid and nonrheumatoid synovial cells to antibody-dependent cell-mediated cytotoxicity

✍ Dr. Marie M. Griffiths; Charles B. Smith; Barbara J. Pepper 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 836 KB

Antibody-dependent cell-mediated cytotox

Antibody-dependent cell-mediated cytotoxicity in treated and nontreated cancer patients

✍ M. L. Stratton; J. Herz; R. A. Loeffler; F. L. McClurg; A. Reiter; P. Bernstein; 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

Antibody-dependent cell-mediated cytotoxicity (ADCC) exhibited by peripheral blood leukocytes was used as a criterion for assessing immune competence of groups of noncancerous individuals and of treated and untreated cancer patients. The results show that, as a group, leukocytes of nontreated cancer